C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2006
12/05/2006	US7145007 Process for the preparation of (pyrimidin-2-yl) methyl ketones
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144889 Triarylimidazoles
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144887 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/03/2006	CA2547744A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
11/2006
11/30/2006	WO2006126938A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126035A2 Process for the preparation of rosuvastatin
11/30/2006	WO2006125809A1 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
11/30/2006	WO2006125746A1 Method for production of 1-alkyl-3-phenyluracils
11/30/2006	WO2006125688A1 Benzoyl-substituted serine amides
11/30/2006	WO2006125555A2 Quinazolinones
11/30/2006	US20060270850 Processes for preparation of pyrimidine derivatives and intermediates
11/30/2006	US20060270849 Process for producing pyrimidin-4-one compound
11/30/2006	US20060270672 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060269956 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
11/30/2006	DE102005024017A1 Chinazolinone Quinazolinones
11/30/2006	CA2609735A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609716A1 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino] benzonitrile
11/30/2006	CA2609392A1 Modulators of atp-binding cassette transporters
11/30/2006	CA2609391A1 Quinazolinones
11/30/2006	CA2609254A1 Benzoyl-substituted serine amides
11/30/2006	CA2609050A1 Method for production of 1-alkyl-3-phenyluracils
11/29/2006	EP1726590A1 Cycloalkanopyridine derivative
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1725540A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
11/29/2006	EP1725539A1 Use of pyrimidine compounds in the preparation of parasiticides
11/29/2006	EP1725239A1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
11/29/2006	EP1581506B1 Use of 2-amino-2h-quinazoline derivatives for producing therapeutic agents
11/29/2006	EP1553947A4 Quinazolinones and derivatives thereof as factor xa inhibitors
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents
11/29/2006	CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006	CN1871222A Ccr3受体拮抗剂 Ccr3 receptor antagonists
11/29/2006	CN1871208A Aralkyl amines as cannabinoid receptor modulators
11/29/2006	CN1871009A 5-arylpyrimidines as anticancer agents
11/29/2006	CN1870896A Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
11/29/2006	CN1869026A Substituted phenyloxy acetamide/propanmide midin derivatire with anticancer activity and its preparation method
11/29/2006	CN1286837C Method for extracting vitamine B2
11/29/2006	CN1286822C Pyrimidinone compounds
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286801C Dielectric substance with block effect preventing copper diffusion
11/28/2006	US7141670 Reacting malondiimate with diketene; chemical intermediate for agriculture products
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	US7141596 Inhibitors of proteins that bind phosphorylated molecules
11/28/2006	US7141575 Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
11/28/2006	US7141567 such as (7R,8R,9R)-8-hydroxy-2-methyl-7-(2-methoxyethoxy)-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridine; for treatment of gastrointestinal disorders
11/28/2006	US7141312 Narrow emission bands, low driver voltages, high photometric efficiency and high thermal stability within a broad spectral range; 2,5-bis-(N-(2,4-dimethoxyphenyl)amino)terephthalic acid diethyl ester for example
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2268775C Process for the preparation of phtalide
11/23/2006	WO2006124657A1 Method for preparing substituted pyrimidines
11/23/2006	WO2006123786A1 Cyanine coloring matter and optical recording medium
11/23/2006	WO2006123726A1 Pharmaceutical composition
11/23/2006	WO2006122631A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators
11/23/2006	WO2006091862A3 Cytokine inhibitors and their use in therapy
11/23/2006	WO2006071762A3 Pyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
11/23/2006	WO2006044732A3 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264625 Platinum complex
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264450 Such as (S)-4-[(3-chloro-4-fluoro-phenyl)amino]-6-[2-(2-oxo-5-methyl-oxazolidin-3-yl)ethyloxy]-7-methoxy-quinazoline; inhibiting signal transduction by tyrosine kinases; treating tumoral diseases and benign prostatic hyperplasia, and diseases of lungs and respiratory tract
11/23/2006	US20060264445 Compounds Capable of Activating Cholinergic Receptors
11/23/2006	US20060264435 Novel compounds
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	DE4245018B4 New alk(en)-yl-terminated liquid crystal cpds. and use as achiral component - for stabilising smectic C phase in chiral tilted smectic medium used in LCD, esp. ferroelectric LCD
11/23/2006	CA2608766A1 2-amino-4-phenylquinazoline derivatives and the use thereof as hsp90 modulators
11/23/2006	CA2608240A1 Multicyclic compounds and methods of their use
11/22/2006	EP1724323A1 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1723946A1 Composition for straightening the hair comprising at least one multi-guanidine not being a hydroxide
11/22/2006	EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006	EP1722798A1 Pyrimidine compounds as purine receptor antagonist
11/22/2006	EP1530574B1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments
11/22/2006	EP1515931B1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1361899B1 Silicon implants comprising a radionucleotide for use in brachytherapy
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	CN1867569A 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents
11/22/2006	CN1867563A Novel imidazole derivatives and their use as pharmaceutical agents
11/22/2006	CN1867561A Novel triarylimidazoles
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867555A Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
11/22/2006	CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors
11/22/2006	CN1867553A Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
11/22/2006	CN1285581C Process for preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285572C Cannabinod receptor ligands
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138398 Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/21/2006	CA2199226C Process for the preparation of unsymmetrical 4,6-bis(aryloxy)pyrimidine compounds
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf

1 ... 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 ... 427